quantisnow
FeedTopReportsPricing
⌘K
Live feed
21:26:27·79d
SECFiling
Univest Financial Corporation logo

SEC Form 13F-HR filed by Univest Financial Corporation

UVSP· Univest Financial Corporation
Finance
Original source

Companies

  • UVSP
    Univest Financial Corporation
    Finance

Recent analyst ratings

  • Dec 3UpdatePiper Sandler$34.00
  • Oct 6UpdateKeefe Bruyette$20.00
  • Nov 7UpdateStephens$30.50
  • Nov 2UpdateRaymond James$34.00

Related

  • SEC2h
    Univest Financial Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
  • SEC1d
    Univest Financial Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR1d
    Univest Financial Corporation Reports First Quarter Results
  • PR16d
    Univest Financial Corporation to Hold First Quarter 2026 Earnings Call
  • SEC21d
    Univest Financial Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • INSIDER37d
    EVP & Chief Credit Officer Monios Eleni S converted options into 1,307 units of Common and covered exercise/tax liability with 444 units of Common, increasing direct ownership by 42% to 2,904 units (SEC Form 4)
  • INSIDER37d
    Sr EVP & CFO Richardson Brian J covered exercise/tax liability with 2,973 units of Common, converted options into 7,964 units of Common and disposed of 1,209 units of Common, increasing direct ownership by 18% to 24,228 units (SEC Form 4)
  • INSIDER37d
    Chairman, President & CEO Schweitzer Jeffrey M converted options into 21,434 units of Common, disposed of 3,273 units of Common and covered exercise/tax liability with 8,018 units of Common, increasing direct ownership by 10% to 110,513 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022